Skip to content
  • HOME
  • ABOUT

    MADE IN AMERICA.

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • ADVOCACY
    • STAFF
    • BOARD
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT CPA
    • ABOUT CPA
    • ADVOCACY
    • STAFF
    • BOARD
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT CPA
    LEARN MORE ➔
  • RESEARCH

    RESEARCH HUB

    The CPA Economics Team is focused on research into policies that can restore broadly shared U.S. prosperity, reduce our huge trade deficit, raise U.S. economic growth rate and reduce inequality.

    VISIT THE RESEARCH HUB

    ECONOMIC ISSUES

    • Trade & Tariffs
    • International Currencies
    • Economic Modeling
    • Industrial Strategy & Industry Studies
    • Labor & Inequality
    • Trade & Tariffs
    • International Currencies
    • Economic Modeling
    • Industrial Strategy & Industry Studies
    • Labor & Inequality

    MORE FROM CPA ECONOMICS

    • JOB QUALITY INDEX
    • CPA Trade Database
    • Domestic Market Share Index
    • Working Papers & Policy Papers
    • JOB QUALITY INDEX
    • CPA Trade Database
    • Domestic Market Share Index
    • Working Papers & Policy Papers
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

    CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

    May 23, 2025

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

    China Solar, Once Biggest Beneficiary of Inflation Reduction Act, No Longer Qualifies

    Distrust Grows: Reuters Report Suggests Chinese Solar Power Inverters Found with “Rogue Communication Device”

    In Senate Small Business Hearing, Democrats Bemoan Tariff “Chaos” as Republicans Increasingly Accept New Thinking on Trade

    MORE FROM THE NEWSROOM ➔
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

U.S. Treasury Staff Finds China Isn’t Manipulating Yuan, Sources Say

ArchiveBy Michael StumoOctober 12, 2018

Editor’s note: 1) First time in history that Treasury staff leak results of currency report before publication. Why, we might ask? 2) Focus upon “manipulation”

China to sacrifice exchange rate to keep economy stable

ArchiveBy Michael StumoOctober 11, 2018

Editor’s note: China’s Central bank has management of exchange rates and the current account balance as part of its job. Our central bank does not. Our

Treasury Spells Out New Rules on Foreign Deals Involving U.S. Technology

ArchiveBy Michael StumoOctober 11, 2018

Editor’s note: CPA supported the bill to strengthen controls on incoming foreign investment. The rules are now being written for implementation.  The Treasury-led interagency committee

Litigation teaches Chinese valsartan maker the downside of U.S. market

ArchiveBy Michael StumoOctober 11, 2018

Editors note: another case of dangerous pharmaceutical drugs coming in from China. Most active pharmaceutical ingredients come from China, having moved out of the USA.

The U.S.-China Trade Battle Spawns a New Era of Tariff Dodges

ArchiveBy Michael StumoOctober 9, 2018

Editors note: Evasion of tariffs through misidentifying tariff codes is not new, but this article is very helpful to focus on the problem. One day

White House report: China’s ‘trade domination’ hinders U.S. manufacturing base

ArchiveBy Michael StumoOctober 5, 2018

Editors note: this is an important report that we have been waiting for. It will be the start of moving our defense industrial supply chain

Press Release: CPA Welcomes Findings of Report on US Defense Industrial Base

ArchiveBy Michael StumoOctober 5, 2018

Trump administration details blueprint to rebuild key manufacturing sectors Washington. The Coalition for a Prosperous America (CPA) today said the Trump administration’s new report on vulnerabilities

August Trade Deficit Hits $53.2 billion; China Trade Deficit Sets Another Monthly Record

ArchiveBy Michael StumoOctober 5, 2018

New trade data from the Department of Commerce shows that America’s trade deficit continues to rise, with the August seasonally-adjusted deficit of $53.2 billion rising 6 percent

U.S. Pivots to China, With Nafta Deal in Hand

ArchiveBy Michael StumoOctober 4, 2018

Editor’s note: This article shows breathtaking infiltration by “strategic competitor” China. It is Soviet style espionage and justifies further aggressive steps to decouple our trade

Pentagon Accuses China of Dumping Products to Undermine U.S. Security

ArchiveBy Michael StumoOctober 4, 2018

Editors note. This report will be very big when it comes out. The trade conflict with China Will continue for a long time. A U.S.

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182838485868788899091
…9293949596…
979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352
353→
  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Youtube Linkedin

© 2025 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • RESEARCH
    • RESEARCH HUB
    • CPA ECONOMIC VIEW
    • TRADE & TARIFFS
    • CURRENCIES
    • MODELING
    • INDUSTRIAL STRATEGIES
    • LABOR & INEQUALITY
    • ECONOMICS CHARTS
    • ECONOMICS PRESENTATIONS
    • CURRENCY MISALIGNMENT MONITOR
    • DOMESTIC MARKET SHARE INDEX
    • TRADE DATABASE
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Twitter
 Facebook
 LinkedIn
 Copy
 Email

Share on Mastodon